HT-DISCOVER

Advancing precision in gene therapies

One of the greatest challenges in genome editing is managing off-target effects – unintended genetic modifications that can compromise both the safety and efficacy of gene therapies. Pioneer Fellow Lilly van de Venn has developed a highly precise and efficient detection method to identify these unwanted mutations with unprecedented accuracy. By significantly improving the reliability of gene editing technologies, her innovation is setting new standards for safer, more trustworthy gene therapies.